Capricor Therapeutics Inc (CAPR)
5.30
-0.10
(-1.85%)
USD |
NASDAQ |
May 10, 16:00
5.30
0.00 (0.00%)
After-Hours: 20:00
Capricor Therapeutics Cash from Investing (TTM): 5.108M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 5.108M |
September 30, 2023 | 16.11M |
June 30, 2023 | 4.215M |
March 31, 2023 | -37.66M |
December 31, 2022 | -35.07M |
September 30, 2022 | -40.58M |
June 30, 2022 | -36.87M |
March 31, 2022 | -1.785M |
December 31, 2021 | -1.196M |
September 30, 2021 | -1.116M |
June 30, 2021 | -0.7995M |
March 31, 2021 | -0.5845M |
December 31, 2020 | 5.439M |
September 30, 2020 | -0.2595M |
June 30, 2020 | -0.1075M |
March 31, 2020 | 0.00 |
December 31, 2019 | -3.002M |
September 30, 2019 | 5.990M |
June 30, 2019 | 5.847M |
March 31, 2019 | 5.845M |
December 31, 2018 | 4.672M |
September 30, 2018 | -1.317M |
June 30, 2018 | -2.189M |
March 31, 2018 | 2.793M |
December 31, 2017 | 4.982M |
Date | Value |
---|---|
September 30, 2017 | -2.628M |
June 30, 2017 | -1.628M |
March 31, 2017 | -6.639M |
December 31, 2016 | -5.191M |
September 30, 2016 | 10.39M |
June 30, 2016 | 12.82M |
March 31, 2016 | 12.83M |
December 31, 2015 | -8.141M |
September 30, 2015 | -12.76M |
June 30, 2015 | -15.24M |
March 31, 2015 | -15.29M |
December 31, 2014 | 0.141M |
September 30, 2014 | 1.041M |
June 30, 2014 | 2.214M |
March 31, 2014 | 3.253M |
December 31, 2013 | 3.778M |
September 30, 2013 | -1.815M |
June 30, 2013 | -2.917M |
March 31, 2013 | -3.886M |
December 31, 2012 | -4.318M |
September 30, 2012 | -0.002M |
June 30, 2012 | -0.002M |
March 31, 2012 | -0.002M |
December 31, 2011 | -0.002M |
September 30, 2011 | -0.0022M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-40.58M
Minimum
Sep 2022
16.11M
Maximum
Sep 2023
-6.122M
Average
-0.5845M
Median
Mar 2021
Cash from Investing (TTM) Benchmarks
Cutera Inc | 137.20M |
Sarepta Therapeutics Inc | 40.50M |
PTC Therapeutics Inc | -262.70M |
Solid Biosciences Inc | 9.689M |
AIM ImmunoTech Inc | -0.832M |